We are live on ! Find out more
XT

XTX Topco Portfolio holdings

AUM $5.75B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
+12.88%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
AUM
$457M
AUM Growth
-$129M
Cap. Flow
-$169M
Cap. Flow %
-37.03%
Top 10 Hldgs %
4.33%
Holding
2,338
New
828
Increased
281
Reduced
395
Closed
822

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$2.95M
2
VTYX
Ventyx Biosciences
VTYX
+$2.44M
3
WMT icon
Walmart Inc
WMT
+$1.99M
4
UNH icon
UnitedHealth
UNH
+$1.8M
5
TSLA icon
Tesla
TSLA
+$1.71M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$3.17M
2
LLY icon
Eli Lilly
LLY
+$2.9M
3
ATVI
Activision Blizzard
ATVI
+$2.88M
4
GWW icon
W.W. Grainger
GWW
+$2.69M
5
V icon
Visa
V
+$2.6M

Sector Composition

Rank Sector Weight
1 Healthcare 15.57%
2 Technology 15.35%
3 Industrials 14.16%
4 Consumer Discretionary 13.85%
5 Financials 12.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KVSA
2301
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
-11,722
Closed -$125K
EQRX
2302
DELISTED
EQRx, Inc. Common Stock
EQRX
-62,767
Closed -$139K
CANO
2303
DELISTED
Cano Health, Inc.
CANO
-371
Closed -$9.41K
CYTO
2304
DELISTED
Altamira Therapeutics Ltd
CYTO
-507
Closed -$2.44K
FRGI
2305
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
-14,803
Closed -$125K
SFR
2306
DELISTED
Appreciate Holdings, Inc. Class A Common Stock
SFR
-14,303
Closed -$2.43K
BRQS
2307
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
-1,210
Closed -$2.6K
AKU
2308
DELISTED
Akumin Inc
AKU
-14,797
Closed -$2.16K
ELYS
2309
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
-11,442
Closed -$5.5K
RAD
2310
DELISTED
Rite Aid Corporation
RAD
-25,828
Closed -$11.6K
ZYNE
2311
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-18,793
Closed -$23.9K
KLR
2312
DELISTED
Kaleyra, Inc.
KLR
-11,578
Closed -$83.8K
CGRN
2313
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
-19,324
Closed -$13.7K
VQS
2314
DELISTED
VIQ SOLUTIONS INC
VQS
-17,540
Closed -$2.81K
UTRS
2315
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
-1,389
Closed -$4.57K
EBET
2316
DELISTED
EBET, INC. Common Stock
EBET
-1,416
Closed -$1.34K
TRTN
2317
DELISTED
Triton International Limited
TRTN
-10,970
Closed -$873K
INFI
2318
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-181,068
Closed -$2.9K
SBIG
2319
DELISTED
SpringBig Holdings, Inc. Common Stock
SBIG
-19,413
Closed -$2.33K
FXLV
2320
DELISTED
F45 Training Holdings Inc.
FXLV
-10,502
Closed -$242
FRBK
2321
DELISTED
Republic First Bancorp Inc
FRBK
-44,703
Closed -$8.49K
AMRS
2322
DELISTED
Amyris Inc.
AMRS
-80,289
Closed -$4.82K
PTRA
2323
DELISTED
Proterra Inc. Common Stock
PTRA
-253,370
Closed -$13.7K
LTCH
2324
DELISTED
Latch, Inc. Common Stock
LTCH
-28,442
Closed -$26.7K
IRNT
2325
DELISTED
IronNet, Inc.
IRNT
-65,472
Closed -$727

Similar funds

XTX Topco's Q4 2023 Portfolio in Review

As of Q4 2023, XTX Topco held 2,338 positions worth $457M, down 22% from $586M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.

XTX Topco withdrew a net $169M in Q4 2023, closing 822 positions and reducing 395 holdings. Its most notable exit was Activision Blizzard, an estimated $2.88M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.

Against the trend, XTX Topco opened a new position in Amazon worth $3.2M.

  • XTX Topco's largest Q4 2023 buy was Amazon: 21,037 shares worth $3.2M.
  • XTX Topco added most to Linde in Q4 2023, an estimated $1.12M increase.
  • XTX Topco's biggest Q4 2023 reduction was Elevance Health, cutting an estimated $3.17M.
  • XTX Topco fully exited Activision Blizzard in Q4 2023, selling an estimated $2.88M.
  • XTX Topco's ten largest holdings make up 4.3% of its $457M portfolio in Q4 2023.
  • XTX Topco opened 828 new positions and closed 822 in Q4 2023.
  • XTX Topco's portfolio value fell 22% quarter-over-quarter to $457M.

Based on XTX Topco's 13F filing for Q4 2023, filed 13 Feb 2024.